hCAIX-IN-11 is a selective inhibitor of carbonic anhydrase IX and XII (hCAIX and hCAXII), with Ki values of 32.7 nM and 623.5 nM, respectively; it targets transmembrane carbonic anhydrase isoforms that serve as biomarkers for certain types of tumors and are involved in maintaining acid-base homeostasis in both normal and cancer cells.